[ad_1] An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said,…
Read More »Therapeutics
[ad_1] KING OF PRUSSIA, Pa., Feb. 22, 2023 /PRNewswire/ — Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO)…
Read More »
[ad_1] Corporate presentation at 10:50 a.m. ET NEW HAVEN, Conn., Feb. 16, 2023 /PRNewswire/ — Trevi Therapeutics, Inc. (Nasdaq: TRVI),…
Read More »
[ad_1] Shares of Viking Therapeutics Inc. VKTX, +4.42% jumped 55% in premarket trading on Monday after a company that is…
Read More »
[ad_1] MarketBeat.com – MarketBeat Biotech stocks are often among the market’s most volatile, and Harpoon Therapeutics Inc. (NASDAQ: HARP) offers…
Read More »
[ad_1] Amgen, which has R&D operations in South San Francisco and has been an opportunistic buyer of Bay Area drug…
Read More »
[ad_1] Check out the companies making headlines in midday trading. Horizon Therapeutics – Shares of the drugmaker jumped 15.5% after…
Read More »
[ad_1] Take a look at some of the biggest movers in the premarket: Horizon Therapeutics (HZNP) – The drugmaker’s shares…
Read More »
[ad_1] The trial is the first to identify a safe, active, non-psychedelic dosage of psilocybin. TORONTO, Dec. 7, 2022 /PRNewswire/…
Read More »
[ad_1] Marvell Technology Group Source: marvell.com Check out the companies making headlines before the bell: Marvell Technology (MRVL) – The…
Read More »